Covid Nasal Vaccine’s Phase 3 Trials Completed: Bharat Biotech Chief
Paris: Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller…